OCUL · Ocular Therapeutix, Inc · Held by Funds
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Registered funds — mutual funds, ETFs and closed-end funds — whose latest Form N-PORT portfolio report holds this exact listed security, matched by CUSIP. Each row is one fund position with its size, value and weight in that fund.
Fund Ownership of OCUL by Fund Type
Registered funds' Form N-PORT reports for the quarter ended Jun 30, 2026Index funds and index ETFs hold 12.76% of shares outstanding.
| Fund type | Of shares outstanding | Shares |
|---|---|---|
| Index funds | 2.94% | 6,472,301 |
| Index ETFs | 9.82% | 21,612,819 |
| Active ETFs | 0.40% | 882,700 |
| Active funds | 13.58% | 29,868,406 |
| Unclassified | 0.00% | 1,702 |
| All registered funds | 26.74% | 58,837,928 |
How fund types are measured
Each fund series counts once, with its latest Form N-PORT report dated inside the quarter; only long share positions count, restated to today's split basis. The fund type is the series' latest Form N-CEN answer on or before the quarter end (the index-fund box and the exchange-traded flag), never its name. Unclassified funds have no usable N-CEN; unit investment trusts are among them, so index ownership is a floor. Funds sit inside their advisers' 13F reports, so these shares overlap the 13F figures and are never added to them.
Funds holding OCUL
197 fund positions| Fund | Ticker | Balance | Value | % of Fund | Side | Reported | Open |
|---|---|---|---|---|---|---|---|
| Fidelity Growth Company Fund | — | 9,704,363 | $101,798,768 | 0.10% | Long | 2026-08-31 | |
| VANGUARD TOTAL STOCK MARKET INDEX FUND | — | 6,616,995 | $64,978,891 | 0.00% | Long | 2026-06-30 | |
| iShares Russell 2000 ETF | IWM | 5,284,839 | $51,897,119 | 0.06% | Long | 2026-06-30 | |
| Fidelity Growth Company K6 Fund | FGKFX | 2,700,674 | $28,330,070 | 0.10% | Long | 2026-08-31 | |
| Fidelity Series Growth Company Fund | FCGSX | 2,611,078 | $27,390,208 | 0.11% | Long | 2026-08-31 | |
| VANGUARD EXTENDED MARKET INDEX FUND | — | 2,003,277 | $19,672,180 | 0.02% | Long | 2026-06-30 | |
| Fidelity Small Cap Index Fund | FSSNX | 2,252,224 | $18,400,670 | 0.05% | Long | 2026-07-31 | |
| T. Rowe Price New Horizons Fund, Inc. | — | 1,789,197 | $17,569,915 | 0.12% | Long | 2026-06-30 | |
| iShares Russell 2000 Growth ETF | IWO | 1,570,555 | $15,422,850 | 0.10% | Long | 2026-06-30 | |
| T. Rowe Price Integrated U.S. Small-Cap Growth Equity Fund | — | 1,484,000 | $14,572,880 | 0.15% | Long | 2026-06-30 | |
| T. Rowe Price Health Sciences Fund, Inc. | — | 1,432,466 | $14,066,816 | 0.12% | Long | 2026-06-30 | |
| Select Pharmaceuticals Portfolio | FPHAX | 1,331,717 | $13,969,711 | 0.86% | Long | 2026-08-31 | |
| VANGUARD RUSSELL 2000 INDEX FUND | — | 1,179,932 | $12,377,487 | 0.07% | Long | 2026-08-31 | |
| Invesco Pharmaceuticals ETF | PJP | 1,489,689 | $12,170,759 | 2.58% | Long | 2026-07-31 | |
| Fidelity Extended Market Index Fund | FSMAX | 864,363 | $9,067,168 | 0.02% | Long | 2026-08-31 | |
| Schwab U.S. Small-Cap ETF | SCHA | 834,834 | $8,757,409 | 0.04% | Long | 2026-08-31 | |
| BlackRock Advantage Small Cap Core Fund | — | 819,090 | $8,592,254 | 0.16% | Long | 2026-08-31 | |
| Select Biotechnology Portfolio | FBIOX | 784,000 | $8,224,160 | 0.13% | Long | 2026-08-31 | |
| Strategic Advisers Fidelity U.S. Total Stock Fund | FCTDX | 736,950 | $7,730,606 | 0.00% | Long | 2026-08-31 | |
| State Street(R) SPDR(R) S&P(R) Pharmaceuticals ETF | XPH | 748,033 | $7,345,684 | 1.71% | Long | 2026-06-30 | |
| Nuveen Quant Small Cap Equity Fund | — | 861,050 | $7,034,779 | 0.17% | Long | 2026-07-31 | |
| Dimensional U.S. Small Cap ETF | DFAS | 655,948 | $5,359,095 | 0.04% | Long | 2026-07-31 | |
| Fidelity Small Cap Growth Fund | — | 640,446 | $5,232,444 | 0.06% | Long | 2026-07-31 | |
| Select Health Care Portfolio | — | 494,535 | $5,187,672 | 0.08% | Long | 2026-08-31 | |
| VANGUARD EXPLORER FUND | — | 615,301 | $5,027,009 | 0.02% | Long | 2026-07-31 | |
| VANGUARD HEALTH CARE INDEX FUND | — | 464,278 | $4,870,276 | 0.02% | Long | 2026-08-31 | |
| U.S. SMALL CAP PORTFOLIO | DFSTX | 561,972 | $4,591,311 | 0.02% | Long | 2026-07-31 | |
| iShares U.S. Pharmaceuticals ETF | IHE | 455,448 | $4,472,499 | 0.39% | Long | 2026-06-30 | |
| Schwab Small-Cap Index Fund | SWSSX | 500,059 | $4,085,482 | 0.05% | Long | 2026-07-31 | |
| U.S. MICRO CAP PORTFOLIO | DFSCX | 487,840 | $3,985,653 | 0.05% | Long | 2026-07-31 | |
| Master Small Cap Index Series | — | 372,908 | $3,661,957 | 0.06% | Long | 2026-06-30 | |
| College Retirement Equities Fund - Total Global Stock Account | — | 357,840 | $3,513,989 | 0.00% | Long | 2026-06-30 | |
| Fidelity Total Market Index Fund | FSKAX | 333,163 | $3,494,880 | 0.00% | Long | 2026-08-31 | |
| iShares Russell 2000 Value ETF | IWN | 332,374 | $3,263,913 | 0.02% | Long | 2026-06-30 | |
| Dimensional U.S. Core Equity 2 ETF | DFAC | 398,601 | $3,256,570 | 0.01% | Long | 2026-07-31 | |
| Fidelity Series Total Market Index Fund | FCFMX | 271,902 | $2,852,252 | 0.00% | Long | 2026-08-31 | |
| BlackRock Health Sciences Opportunities Portfolio | — | 258,781 | $2,714,613 | 0.04% | Long | 2026-08-31 | |
| Allspring Small Company Growth Fund | — | 329,464 | $2,691,721 | 0.53% | Long | 2026-07-31 | |
| Fidelity Small Cap Growth K6 Fund | FOCSX | 329,204 | $2,689,597 | 0.06% | Long | 2026-07-31 | |
| Optimum Small-Mid Cap Growth Fund | — | 248,048 | $2,435,831 | 0.26% | Long | 2026-06-30 | |
| iShares Core S&P Total U.S. Stock Market ETF | ITOT | 237,680 | $2,334,018 | 0.00% | Long | 2026-06-30 | |
| Fidelity Advisor Health Care Fund | — | 277,371 | $2,266,121 | 0.07% | Long | 2026-07-31 | |
| Nuveen Small Cap Blend Index Fund | — | 272,503 | $2,226,350 | 0.05% | Long | 2026-07-31 | |
| EQ/2000 Managed Volatility Portfolio | — | 223,496 | $2,194,731 | 0.06% | Long | 2026-06-30 | |
| VANGUARD RUSSELL 2000 GROWTH INDEX FUND | — | 185,806 | $1,949,105 | 0.11% | Long | 2026-08-31 | |
| T.Rowe Price Small Cap Growth Portfolio | — | 166,578 | $1,635,796 | 0.14% | Long | 2026-06-30 | |
| BlackRock Advantage Small Cap Growth Fund | — | 163,372 | $1,604,313 | 0.19% | Long | 2026-06-30 | |
| Fidelity Small Cap Growth Index Fund | FECGX | 159,430 | $1,565,603 | 0.10% | Long | 2026-06-30 | |
| Strategic Advisers U.S. Total Stock Fund | FSAKX | 148,582 | $1,558,625 | 0.00% | Long | 2026-08-31 | |
| WesMark Small Company Fund | WMKSX | 149,000 | $1,463,180 | 0.78% | Long | 2026-06-30 |